190 related articles for article (PubMed ID: 15172874)
1. Systematic review of mifepristone for the treatment of uterine leiomyomata.
Steinauer J; Pritts EA; Jackson R; Jacoby AF
Obstet Gynecol; 2004 Jun; 103(6):1331-6. PubMed ID: 15172874
[TBL] [Abstract][Full Text] [Related]
2. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
Fiscella K; Eisinger SH; Meldrum S; Feng C; Fisher SG; Guzick DS
Obstet Gynecol; 2006 Dec; 108(6):1381-7. PubMed ID: 17138770
[TBL] [Abstract][Full Text] [Related]
3. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
Eisinger SH; Fiscella J; Bonfiglio T; Meldrum S; Fiscella K
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):215-8. PubMed ID: 19586708
[TBL] [Abstract][Full Text] [Related]
4. Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial.
Bagaria M; Suneja A; Vaid NB; Guleria K; Mishra K
Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):77-83. PubMed ID: 19281585
[TBL] [Abstract][Full Text] [Related]
5. Low-dose mifepristone for uterine leiomyomata.
Eisinger SH; Meldrum S; Fiscella K; le Roux HD; Guzick DS
Obstet Gynecol; 2003 Feb; 101(2):243-50. PubMed ID: 12576246
[TBL] [Abstract][Full Text] [Related]
6. Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.
Liu C; Lu Q; Qu H; Geng L; Bian M; Huang M; Wang H; Zhang Y; Wen Z; Zheng S; Zhang Z
Medicine (Baltimore); 2017 Feb; 96(7):e6124. PubMed ID: 28207540
[TBL] [Abstract][Full Text] [Related]
7. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
[TBL] [Abstract][Full Text] [Related]
8. Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis.
Shen Q; Hua Y; Jiang W; Zhang W; Chen M; Zhu X
Fertil Steril; 2013 Dec; 100(6):1722-6.e1-10. PubMed ID: 24094421
[TBL] [Abstract][Full Text] [Related]
9. Treatment of uterine myoma with 5 or 10mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial.
Esteve JL; Acosta R; Pérez Y; Campos R; Hernández AV; Texidó CS
Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):202-8. PubMed ID: 22269473
[TBL] [Abstract][Full Text] [Related]
10. Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial.
Carbonell Esteve JL; Acosta R; Heredia B; Pérez Y; Castañeda MC; Hernández AV
Obstet Gynecol; 2008 Nov; 112(5):1029-36. PubMed ID: 18978102
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of uterine leiomyoma by two different doses of mifepristone].
Yang Y; Zheng S; Li K
Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):624-6. PubMed ID: 9275461
[TBL] [Abstract][Full Text] [Related]
12. Network meta-analysis of 6 kinds of Chinese patent medicines combined with mifepristone in the treatment of uterine fibroids: A protocol for systematic review and network meta-analysis.
Bi C; Qiao M; Jia Y; Wang H
Medicine (Baltimore); 2021 Oct; 100(42):e27523. PubMed ID: 34678886
[TBL] [Abstract][Full Text] [Related]
13. Mifepristone for uterine fibroids.
Tristan M; Orozco LJ; Steed A; Ramírez-Morera A; Stone P
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007687. PubMed ID: 22895965
[TBL] [Abstract][Full Text] [Related]
14. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
Zeng C; Gu M; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
[TBL] [Abstract][Full Text] [Related]
15. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial.
Fiscella K; Eisinger S
Obstet Gynecol; 2008 Sep; 112(3):707; author reply 707-8. PubMed ID: 18757682
[No Abstract] [Full Text] [Related]
16. [Role of mifepristone for the treatment of uterine fibroid].
Malartic C; Morel O; Akerman G; Tulpin L; Desfeux P; Barranger E
Gynecol Obstet Fertil; 2008 Jun; 36(6):668-74. PubMed ID: 18539512
[TBL] [Abstract][Full Text] [Related]
17. Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas.
Eisinger SH; Bonfiglio T; Fiscella K; Meldrum S; Guzick DS
J Minim Invasive Gynecol; 2005; 12(3):227-33. PubMed ID: 15922980
[TBL] [Abstract][Full Text] [Related]
18. [Effects of mifepristone on estrogen and progestin receptors in human uterine leiomyoma].
Wang H; Jin J
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):79-81. PubMed ID: 11809103
[TBL] [Abstract][Full Text] [Related]
19. Re: Low-dose mifepristone: Effects on the endometrium. Aust N Z J Obstet Gynaecol 2009; 49: 77-83.
Fraser IS
Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):342. PubMed ID: 19566579
[No Abstract] [Full Text] [Related]
20. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]